ROADMAP

PHASE 1 (2015 – 16)

Safety, Dose-ranging & Efficacy

PHASE 2A (2017 – 18)

Efficacy new formulation

PHASE 2B (2018 – 19)

Double blind, placebo controlled

PHASE 3 ( 2019 – )

Large population study